NO167740C - Analogifremgangsmaate for fremstilling av terapeutisk akive 7beta-(fluormetyltio)-acetamido-7alfa-metoksy-3-(1-(2-hydroksyalkyl)-1h-tetrazol-5-yl)-tiometyl-1-detia-1-oksa-3-cephem-4-karboksylderivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk akive 7beta-(fluormetyltio)-acetamido-7alfa-metoksy-3-(1-(2-hydroksyalkyl)-1h-tetrazol-5-yl)-tiometyl-1-detia-1-oksa-3-cephem-4-karboksylderivater.

Info

Publication number
NO167740C
NO167740C NO834729A NO834729A NO167740C NO 167740 C NO167740 C NO 167740C NO 834729 A NO834729 A NO 834729A NO 834729 A NO834729 A NO 834729A NO 167740 C NO167740 C NO 167740C
Authority
NO
Norway
Prior art keywords
dythomethyl
tyomethyl
fluormethyltio
7alfa
hydroxylkyl
Prior art date
Application number
NO834729A
Other languages
English (en)
Norwegian (no)
Other versions
NO167740B (no
NO834729L (no
Inventor
Teruji Tsuji
Hisao Sato
Yoshio Hamashima
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO834729L publication Critical patent/NO834729L/no
Publication of NO167740B publication Critical patent/NO167740B/no
Publication of NO167740C publication Critical patent/NO167740C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
NO834729A 1982-12-23 1983-12-21 Analogifremgangsmaate for fremstilling av terapeutisk akive 7beta-(fluormetyltio)-acetamido-7alfa-metoksy-3-(1-(2-hydroksyalkyl)-1h-tetrazol-5-yl)-tiometyl-1-detia-1-oksa-3-cephem-4-karboksylderivater. NO167740C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57234472A JPS59139385A (ja) 1982-12-23 1982-12-23 フルオロメチルチオオキサセフアロスポリン

Publications (3)

Publication Number Publication Date
NO834729L NO834729L (no) 1984-06-25
NO167740B NO167740B (no) 1991-08-26
NO167740C true NO167740C (no) 1991-12-04

Family

ID=16971542

Family Applications (1)

Application Number Title Priority Date Filing Date
NO834729A NO167740C (no) 1982-12-23 1983-12-21 Analogifremgangsmaate for fremstilling av terapeutisk akive 7beta-(fluormetyltio)-acetamido-7alfa-metoksy-3-(1-(2-hydroksyalkyl)-1h-tetrazol-5-yl)-tiometyl-1-detia-1-oksa-3-cephem-4-karboksylderivater.

Country Status (26)

Country Link
US (1) US4532233A (ko)
JP (1) JPS59139385A (ko)
KR (1) KR890000095B1 (ko)
AT (1) AT383807B (ko)
AU (1) AU558547B2 (ko)
BE (1) BE898541A (ko)
CA (1) CA1236099A (ko)
CH (1) CH656619A5 (ko)
DE (1) DE3345989A1 (ko)
DK (1) DK159447C (ko)
ES (6) ES8506024A1 (ko)
FI (1) FI74016C (ko)
FR (1) FR2538391B1 (ko)
GB (1) GB2132198B (ko)
HK (1) HK89988A (ko)
HU (1) HU189014B (ko)
IE (1) IE56401B1 (ko)
IL (1) IL70488A (ko)
IT (1) IT1160238B (ko)
NL (1) NL192740C (ko)
NO (1) NO167740C (ko)
NZ (1) NZ206413A (ko)
PH (1) PH19352A (ko)
PT (1) PT77831B (ko)
SE (2) SE461527B (ko)
ZA (1) ZA838920B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
JP2004168775A (ja) * 2002-11-08 2004-06-17 Orchid Chemicals & Pharmaceuticals Ltd オキサセファロスポリンの改良合成法
KR100832757B1 (ko) 2004-02-20 2008-05-27 시오노기세이야쿠가부시키가이샤 옥사세펨의 결정
KR20080111062A (ko) * 2006-03-15 2008-12-22 카르테시아 에스.에이.에스. 디 엠마누엘라 미글리아바카 앤 씨. （1­옥사­또는 1­티아­）3­세펨 유도체의 제조 방법
CN102952149B (zh) * 2012-11-09 2015-06-24 浙江新和成股份有限公司 一种氟氧头孢中间体的一锅合成法
KR101314500B1 (ko) * 2012-12-28 2013-10-07 제일약품주식회사 안정성이 개선된 옥사세펨 제제 및 그 제조방법
CN103524534B (zh) * 2013-09-02 2016-08-17 上海龙翔生物医药开发有限公司 氟氧头孢钠的制备方法
CN104327100B (zh) * 2014-09-30 2016-09-28 华北制药河北华民药业有限责任公司 高纯度氟氧头孢钠制备工艺
CN105399755B (zh) * 2015-11-03 2018-05-11 浙江永宁药业股份有限公司 一种氟氧头孢酸的合成方法
CN105801601B (zh) * 2016-04-02 2018-01-26 丽珠医药集团股份有限公司 一种氟氧头孢钠合成方法
CN108424418A (zh) * 2017-02-15 2018-08-21 山东致纯医药科技有限公司 一种氟氧头孢钠杂质
KR102115644B1 (ko) * 2017-09-13 2020-05-27 주식회사 동도물산 7α-알콕시옥사세펨 중간체의 제조방법
CN110028522A (zh) * 2019-04-22 2019-07-19 山西千岫制药有限公司 一种氟氧头孢母核的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5419990A (en) * 1977-07-14 1979-02-15 Shionogi & Co Ltd Dihydrotriazinylthioxacephalosporin
JPS5690088A (en) * 1979-11-02 1981-07-21 Meiji Seika Kaisha Ltd Novel cephalosporin analog compound
JPS56103185A (en) * 1980-01-22 1981-08-18 Shionogi & Co Ltd Malonamidoxa-dethia-cephem compound

Also Published As

Publication number Publication date
IE832951L (en) 1984-06-23
ZA838920B (en) 1984-07-25
NL192740C (nl) 1998-01-06
NZ206413A (en) 1986-05-09
GB8333186D0 (en) 1984-01-18
ES8703458A1 (es) 1987-02-16
IT8368343A0 (it) 1983-12-22
NL8304409A (nl) 1984-07-16
AT383807B (de) 1987-08-25
DK159447B (da) 1990-10-15
BE898541A (fr) 1984-04-16
NL192740B (nl) 1997-09-01
PT77831A (en) 1984-01-01
AU2211383A (en) 1984-06-28
CA1236099A (en) 1988-05-03
HU189014B (en) 1986-06-30
ATA446883A (de) 1987-01-15
HK89988A (en) 1988-11-11
US4532233A (en) 1985-07-30
KR840007007A (ko) 1984-12-04
IL70488A0 (en) 1984-03-30
ES534290A0 (es) 1985-06-01
ES8505671A1 (es) 1985-06-01
ES534288A0 (es) 1985-06-01
NO167740B (no) 1991-08-26
SE8802008D0 (sv) 1988-05-30
GB2132198A (en) 1984-07-04
ES527595A0 (es) 1985-06-16
ES8506024A1 (es) 1985-06-16
PH19352A (en) 1986-04-02
ES8505670A1 (es) 1985-06-01
CH656619A5 (de) 1986-07-15
SE461527B (sv) 1990-02-26
JPS6225671B2 (ko) 1987-06-04
DK159447C (da) 1991-04-08
FR2538391A1 (fr) 1984-06-29
PT77831B (en) 1986-03-26
ES534291A0 (es) 1987-02-16
SE8802008L (sv) 1988-05-30
DE3345989C2 (ko) 1992-09-24
FI834682A (fi) 1984-06-24
SE8307079L (sv) 1984-06-24
ES534289A0 (es) 1985-06-01
FR2538391B1 (fr) 1986-12-19
FI74016B (fi) 1987-08-31
GB2132198B (en) 1986-10-01
IT1160238B (it) 1987-03-04
NO834729L (no) 1984-06-25
CA1259989C (ko) 1989-09-26
SE8307079D0 (sv) 1983-12-21
KR890000095B1 (ko) 1989-03-07
FI74016C (fi) 1987-12-10
FI834682A0 (fi) 1983-12-19
IE56401B1 (en) 1991-07-17
ES8708227A1 (es) 1987-10-01
ES8505672A1 (es) 1985-06-01
DK589583D0 (da) 1983-12-21
SE470132B (sv) 1993-11-15
DK589583A (da) 1984-06-24
DE3345989A1 (de) 1984-06-28
ES556846A0 (es) 1987-10-01
IL70488A (en) 1988-03-31
AU558547B2 (en) 1987-02-05
JPS59139385A (ja) 1984-08-10
HUT34200A (en) 1985-02-28

Similar Documents

Publication Publication Date Title
NO164835C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO162764C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinderivater.
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO163451C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminomethyloxooxazolidinylbenzenderivater.
NO161117C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
NO161372C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive guaninderivater.
NO159531C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO156864C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO159446C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO152129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO831610L (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxicamderivater.
NO164301C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
NO159654C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO167740C (no) Analogifremgangsmaate for fremstilling av terapeutisk akive 7beta-(fluormetyltio)-acetamido-7alfa-metoksy-3-(1-(2-hydroksyalkyl)-1h-tetrazol-5-yl)-tiometyl-1-detia-1-oksa-3-cephem-4-karboksylderivater.
NO162155C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylkarbonoksylsyrederivater.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO161738C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive imidazolinderivater.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.